Below are new healthcare stock indexes I have created, revised, and tracked over the past few years which are now featured at a new website called Investars YOU. The new site includes automated index tracking and allows investors to create custom stock portfolios based on their individual preferences with the ability to invest real money by linking your brokerage account.
The Cosmetic and Restorative Medicine Index (CRM) tracks the performance of companies that derive over 50% of revenue from any of the following activities: (1) prescription skin care therapeutics; (2) medical devices, products, services, OR equipment for procedures which are intended to enhance appearance; (3) medical devices, products, services, OR equipment for use as joint replacements, tissue repair agents, tissue reconstruction agents, surgical adhesives, and cardiovascular procedures; and (4) regenerative medicine products, services, and/or an active clinical pipeline which seeks to restore or repair the functionality of lost or damaged organ, tissue, cellular, and genetic material.
The CRM Index is organized to include companies which either enhance appearance or restore bodily functions (with increased demand expected from an aging Baby Boomer population and as medical advances allow people to live longer) – including a breakdown of approximately 15% stem cells + regenerative medicine, 25% skin care + cosmetic medicine, 30% orthopedic repair + implants, and 30% cardiovascular repair + implants.
The <font> Global Stem Cell Index </font> tracks the performance of regenerative medicine companies (with stock prices of at least 15 cents at the time of inclusion) which derive over 50% of revenue or have compound(s) in active pre-clinical or clinical development which are designed to restore, replace, repair, or enhance the functionality or appearance of tissue and organ systems, including all types of embryonic and adult stem cell therapeutics. In addition, all types of products and services for stem cell banking are included in this index.
The Global Generic Drug Index tracks the performance of companies which meet any of the following three requirements: (1) derive either $500 million (USD) OR more than 50% of trailing 12-month revenues from the manufacture and sale of any type of generic (off-patent) prescription or over-the-counter (OTC) drug product intended for use by humans, including contract manufacturing services for drug products and biological agents; (2) have one or more compound(s) in active clinical development OR have a pending ANDA with the FDA for a generic drug candidate; (3) have received FDA approval for an abbreviated new drug application (ANDA) within the past 12 months.
Favorable growth trends for the generic drug industry include about $70 billion in brand name drug sales with patent expirations through 2012, a push to increase generic substitution rates from 65% of all prescriptions dispensed to over 70%, continued industry consolidation of small and mid-caps by industry leaders such as Teva Pharma (NASDAQ:TEVA) and Mylan Labs (NYSE:MYL), and news this past week that seven years is an appropriate time period to protect brand-name biotechnology medicines from cheaper generic rivals compared to industry groups which are lobbying for 12-14 years of marketing exclusivity as legislators debate a regulatory pathway for generic versions of biological agents.
The Global Tobacco Index tracks the performance of companies which derive over 50% of their revenue from the distribution or manufacturing of any type of tobacco product (e.g. cigarettes, cigars, chewing tobacco) or any related tobacco supplies (e.g. wrapping papers, tobacco leafs, filters). Last week, President Obama signed into law a measure giving the FDA regulatory authority over tobacco products and tobacco use represents a major cause of preventable deaths and healthcare costs in this country and around the world.
However, from an investment standpoint, companies such as Altria (NYSE:MO) with a dividend yield near 8% may actually benefit from the measure which effectively prevents new tobacco products from entering the market, restricts marketing, but falls short of allowing the outright ban of all tobacco products.
The Health Benefit Providers Index is passively managed to track the performance of retail pharmacies, pharmacy benefit managers, managed care companies, health insurers, hospital pharmacy operators, workers compensation insurers, and specialty health benefit providers. Companies in this index such as UnitedHealth (NYSE:UNH) and Aetna (NYSE:AET) have bounced off multi-year stock price lows on the prospect of less sweeping healthcare reform than originally feared, including the profit-less prospect of competing against a public, government-run healthcare plan.
The Global Health Information Technology (Health IT) Index tracks the performance of companies which derive the majority of their revenue from the following activities: (1) the electronic transmission, storage, and processing of prescriptions (e-prescribing); (2) electronic storage and systems for healthcare facility operations and medical records; and (3) electronic systems, devices, and services for remote, real-time monitoring of patient health parameters (telemedicine).
Despite uncertainties over the prospects for major healthcare reform, increased spending on Health IT is widely recognized as an important feature to modernize medical records, measure healthcare outcomes, and improve/extend the reach of modern healthcare technology through remote patient monitoring and other related technologies.
The Health IT index has easily outpaced the overall market on a year-to-date basis (YTD), including some top YTD stock price gainers from the index such as Allscripts-Misys (NASDAQ:MDRX) (+48.6%), Eclipsys (NASDAQ:ECLP) (+27.2%), Cerner (NASDAQ:CERN) (+60.2%), Computer Programs & Systems (NASDAQ:CPSI) (+42.3%), Quality Systems (NASDAQ:QSII) (+29.5%), Zix Corp (NASDAQ:ZIXI) (+52%), and Merge Healthcare (NASDAQ:MRGE) (+236%).
The Preventive Medicine Index passively tracks the performance of companies with market caps over $100 million at the time of inclusion that derive over either 50% or $100 million in trailing 12-month revenue from any of the following activities: (1) human vaccines which are already on the market or in active clinical development; (2) diagnostics and lab services; (3) diabetes care; and (4) vitamins, health supplements, functional foods, and weight loss products or services. Index components will be removed to reflect corporate events such as mergers and bankruptcies which result in de-listing of the underlying stocks.
An index of companies involved in diagnostics, lab services, diabetes care, and vaccines which have positive growth trends and represent M&A targets for big pharma companies, such as Pfizer's (NYSE:PFE) pending acquisition of Wyeth (NYSE:WYE) in which PFE cited Wyeth's high-growth vaccine + biological agent business as a major reason for the deal. Crucell (NASDAQ:CRXL) represents the largest pure-play vaccine maker with a market cap of $1.6B, and the stock has gained about 35% since I wrote about it in January as a possible takeover target.
The closely related <font> Emerging Diagnostics Index </font> tracks the performance of companies with market caps below $250 million at the time of inclusion. The index includes diabetes monitoring device makers, laboratory services, clinical diagnostics, diagnostic imaging, diagnostic equipment makers, and molecular diagnostics.
The <font> Cancer Diagnostic & Therapeutic (Dx/Tx) Micro-Cap Index </font> constituents reflect a cross-section of emerging cancer companies with market caps below $250 million at the inception date of 4/12/09, including (1) diagnostics (molecular diagnostics and device-based diagnostics), (2) lab services (personalized medicine applications to guide and track the effectiveness of cancer treatments), (3) drug discovery (screening and modifying compounds to achieve anti-cancer effects during the early stages of preclinical and Phase 1 clinical studies), (4) immunotherapy (a.k.a. cancer vaccines which are designed to stimulate the immune system to eradicate cancer), and (5) commercial or late-stage (Phase 2-3) clinical development.
A World Health Organization report released last year estimates that cancer will overtake heart disease as the top cause of death in the world by 2010, which is part of an overall trend that predicts global cancer cases and deaths will more than double by 2030. In addition to the urgent need for safer and more effective cancer treatments; advances in genetic testing and screening have the potential to diagnosis the disease at much earlier stages and can also be used to monitor and guide the treatment process.
Yout must have heared Louis Vuitton Outlet.Louis Vuitton brand also could let you shake.Louis Vuitton Outlet Store Offer the Products that you love.You Could buy Louis Vuitton you like.If you go shopping or walk on the street with Louis Vuitton handbags and purses,people must envy you and feel you are very noble and self-confident.
By the skin of the animal most heels into low, these animals were killed, Christian Louboutin shoes Louboutin saleand skinning, cutting, Christian Louboutin make high heels after being women jade is sufficient underfoot, this process easily mobilized males to women's natural worship complex. Christian Louboutin on saleSenior who they are often unreal high-heeled shoes wanderlust cheap Christian Louboutin Want to his feet were killed to become a woman of lower animals - his skin was made from the high-heeled shoes, Christian Louboutin discount the tongue is compressed into upper part of leather soles internal high-heeled shoes have been fashioned into pads, bones, hair is the heel of my heels of woven women stockings... louboutins These very imagination, often make men with masturbation behavior and acquired satisfied. Maybe it's not normal mental imagination, Christian Louboutin salebut human psychological originally not normal! Aggressive, seek hegemony, selfish, 2011 Christian Louboutin shoes play right and show off, jealousy, lie... This world where will be a psychological completely normal person? Christian Louboutin heelsHigh-heeled shoes in the physical level the heel of my only a few centimeters or ten centimeters, but it's the short size but can make women are on high, Christian Louboutin UK as if can put the world underfoot. In this sense, its spirit height in male heart cannot be measured. It is a long story, Christian Louboutin because the beauty of high-heeled shoes from whatever perspective, she is sexy, full of temptation was! For example, Christian Louboutin shoes high heels with the heel of my shoes can form a triangle, palm parts from the side looks, this simply is the world's most sexy shape! The triangle formed by the gap if used to store content, louboutinthen can hold all the man's heart, it is no exaggeration!
By the skin of the animal most heels into low, these animals were killed, Christian Louboutin shoes Louboutin saleand skinning, cutting, Christian Louboutin make high heels after being women jade is sufficient underfoot, this process easily mobilized males to women's natural worship complex. Christian Louboutin on saleSenior who they are often unreal high-heeled shoes wanderlust cheap Christian Louboutin Want to his feet were killed to become a woman of lower animals - his skin was made from the high-heeled shoes, Christian Louboutin discount the tongue is compressed into upper part of leather soles internal high-heeled shoes have been fashioned into pads, bones, hair is the heel of my heels of woven women stockings... louboutins These very imagination, often make men with masturbation behavior and acquired satisfied. Maybe it's not normal mental imagination, Christian Louboutin salebut human psychological originally not normal! Aggressive, seek hegemony, selfish, 2011 Christian Louboutin shoes play right and show off, jealousy, lie... This world where will be a psychological completely normal person? Christian Louboutin heelsHigh-heeled shoes in the physical level the heel of my only a few centimeters or ten centimeters, but it's the short size but can make women are on high, Christian Louboutin UK as if can put the world underfoot. In this sense, its spirit height in male heart cannot be measured. It is a long story, Christian Louboutin because the beauty of high-heeled shoes from whatever perspective, she is sexy, full of temptation was! For example, Christian Louboutin shoes high heels with the heel of my shoes can form a triangle, palm parts from the side looks, this simply is the world's most sexy shape! The triangle formed by the gap if used to store content, louboutinthen can hold all the man's heart, it is no exaggeration!
A Replica Breitling is a timepiece of high quality and functionality and you will have all the class, prestige and luxury of a wealthy, successful individual. By choosing from our selection of luxury Replica Watches , you can improve your self-esteem and feel confident to enter new circles of business associates and friends. These Rolex Replicas will surely enhance your style and only you will know the watch you wear did not cost you $1,000's of dollars.
We have been in business for more than 7 years! We offer high quality Swiss-made Watch Cases and Quartz Movement from Japan. Feel secure with our Safe & Secure Shopping - 256-bit SSL encryption, Quick Shipping (about 10 days or less).
Sacs Louis Vuitton ou la chasse paraphé produits est observée depuis les kilos principauxLesaca près les sacs LV Monogram Canvas dans le collège centré. vraimentreconnue peut êtred'acquérir un sac à conjointet jeunesse recommandations cru sur la façon de chasserfacteursCinquante Eole Eole BT, les suivants 55Keepall Louis, qui se composent de sacs à main en alternance significative et motos Cruiser quel'exquis plusieurs heures Alizé avec LVautres bagages. Louis Vuitton Speedy abordable pour n'importe quel montant dénombrables de nombreuses années maintenant ou à proximité de la découverte fondée en mouvementunesuperbe fournissent près de Lv bonnequi bagages Speedy. Mais, je accepter que ce pourrait être le monogramme LV à acheter probablement le plus enchanté par la production del'utilisation du support.
Abercrombie And Fitch y compris les hoodies Abercrombie, vestes Abercrombie, Abercrombiemanteaux, etc sont populaires partout dans le world.Doudoune Abercrombie Fitch pour les femmes sont enlacés conique et corps pour un look sophistiqué et élégant. Ils sont rembourrés pour la chaleur avec conçues avec des broderies fines pour donner un toucher doux. Le Helenfausse fourrure veste polaire et Helen Faux vestes en fourrure capuche ouatés sont très populaires auprès des femmes. Celeste doublé de fourrure vestes et blousons parka Rylie sont également populaires auprès des femmes. Vestes femmes viennent dans les couleurs traditionnelles comme le marron, olive, nef, blanc, crème, ainsi que dans les rouges et roses. Le logo est mis en évidence Abercrombie brodé sur le devant la plupart du temps.
Sacoche Louis Vuitton est l'un de vos possibilités les plus exceptionnels pour les composantsutilisés sac de chasse bags.The pour gagner, penser à la façon d'identifier l'allusion, est vraiment monogramme substance, une substance identifiée comme c'est ténacité ainsi que lacréation d'aucune différence si elles sont riches avantage brossé.L ce sac Vuitton Monogrammatériau est fondée sur des composants de chasse monogramme est considérée comme la diversification il arrive avec, qui font de créer applicationidéale utilisation de comme un«bagage» des conteneurs. diverses modificationssommeil d'autres, au sein d'exactement le système du centre consistent exactement les mêmes de la bande nue, sans aucun douteextrêmement minuscule quantité de sacs à main qui ont lieu à l'élaboration d'utilisation de la bande obtenue, comme un as face est sans doute offert par la fonte mélangée légèrement.posséder une marque de la marque de diamètre intérieur (le type qui tirent profit des compagnies aériennes pour les sacs de l'identité individuelle), les Sacs Louis Vuitton fera parmi l'un des efforts les plus utiles à dos, surtout pour tous ceux qui voyagez léger offre ".
Data powered by FinancialContent.
All Rights Reserved.
Quotes delayed at least 20 minutes unless otherwise indicated.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.
$16.48 (06/27/09)
